FDA removes the contraindication for use of Bracco Diagnostics Inc.’s LUMASON® in patients with cardiac shunts

Read the press release here.

Share

CMS finalized increase to echo code 93306 and accepted the cardiology community’s proposal that prevents cuts to echoes with contrast